跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-METHYLPHENIDATE ER - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
APO-METHYLPHENIDATE ER
Authorized
STANDARD
APO-METHYLPHENIDATE ER
Apotex Inc
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
fb8edd1aa47d4c56
Company
Apotex Inc
Type
Standard
Approval Details
Approval Id
fb8edd1aa47d4c56
Drug Approval Canada Name
APO-METHYLPHENIDATE ER
Product Name
APO-METHYLPHENIDATE ER
Status
Marketed
Status Date
2016-07-22
Original Market Date
2016-07-22
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
CONTROLLED DRUGS (CDSA III)
Ahfs
28:20.32
Atc Original
N06BA04 METHYLPHENIDATE
Aig Number
0107548004
Company Name
Apotex Inc
Company Address
150 Signet Drive Toronto Ontario Canada M9L 1T9
Company Detail Path
/organization/apotex-inc
Company Information
Pharmaceutical Company Name
Apotex Inc
Country Name
Canada
Province Name
Ontario
City Name
toronto,ontario,country_ca
Address
150 Signet Dr
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
fb8edd1aa47d4c56
Type
Standard
Back to Health Canada Approvals